26
|
Richez U, Latremouille C, Netuka I, Roussel J, Saubamea B, Rossi E, Kindo M, Pya Y, Capel A, Jansen P, Carpentier A, Smadja D. Hemocompatibility of Bioprosthetic valve in bovine pericardium is based on fibrin formation and its endothelization. ARCHIVES OF CARDIOVASCULAR DISEASES SUPPLEMENTS 2019. [DOI: 10.1016/j.acvdsp.2019.02.157] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
27
|
Schussler O, Lila N, Perneger T, Mootoosamy P, Grau J, Francois A, Smadja DM, Lecarpentier Y, Ruel M, Carpentier A. Recipients with blood group A associated with longer survival rates in cardiac valvular bioprostheses. EBioMedicine 2019; 42:54-63. [PMID: 30878598 PMCID: PMC6491382 DOI: 10.1016/j.ebiom.2019.02.047] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/03/2018] [Revised: 02/12/2019] [Accepted: 02/20/2019] [Indexed: 01/02/2023] Open
Abstract
Background Pigs/bovines share with humans some of the antigens present on cardiac valves. Two such antigens are: the major xenogenic Ag, “Gal” present in all pig/bovine very close to human B-antigen of ABO-blood-group system; the minor Ag, pig histo-blood-group AH-antigen identical to human AH-antigen and present by some animals. We hypothesize that these antigens may modify the immunogenicity of the bioprosthesis and also its longevity. ABO distribution may vary between patients with low (<6 years) and high (≥15 years) bioprostheses longevity. Methods Single-centre registry study (Paris, France) including all degenerative porcine bioprostheses (mostly Carpentier-Edwards 2nd/3rd generation heart valves) explanted between 1985 and 1998 and some bovine bioprostheses. For period 1998–2014, all porcine bioprostheses with longevity ≥13 years (follow-up ≥29 years). Important predictive factors for bioprosthesis longevity: number, site of implantation, age were collected. Blood group and other variables were entered into an ordinal logistic regression analysis model predicting valve longevity, categorized as low (<6 years), medium (6–14.9 years), and high (≥15 years). Findings Longevity and ABO-blood group were obtained for 483 explanted porcine bioprostheses. Mean longevity was 10.2 ± 3.9 years [0–28] and significantly higher for A-patients than others (P = 0.009). Using multivariate analysis, group A was a strong predictive factor of longevity (OR 2.09; P < 0.001). For the 64 explanted bovine bioprosthesis with low/medium longevity, the association, with A-group was even more significant. Interpretation Patients of A-group but not B have a higher longevity of their bioprostheses. Future graft-host phenotyping and matching may give rise to a new generation of long-lasting bioprosthesis for implantation in humans, especially for the younger population. Fund None.
Collapse
|
28
|
Lemasson J, Baroudjian B, Doucet L, Vitaux H, Herms F, Carpentier A, Lebbé C, Gounant V, Hautefort C, Delyon J. Toxicité audiovestibulaire des immunothérapies : première série de 4 cas. Ann Dermatol Venereol 2018. [DOI: 10.1016/j.annder.2018.09.509] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
29
|
Cuzzubbo S, Ursu R, Mazoyer J, Belin C, Baroudjian B, Lebbe C, Carpentier A. P05.76 Resuming treatment with immune checkpoint inhibitors in cancer patients who developed immune-related meningitis. Neuro Oncol 2018. [DOI: 10.1093/neuonc/noy139.402] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
30
|
URSU R, Thomas L, Psimaras D, Chinot O, Le Rhun E, Ricard D, Charissoux M, Cuzzubbo S, Sejalon F, Quillien V, Hoang-Xuan K, Ducray F, Portal J, Levy-Piedbois C, Vicaut E, Carpentier A. OS2.4 Angiotensin II Receptor Blockers, steroids and radiotherapy in glioblastoma - A randomized multicenter trial (ASTER Trial). An ANOCEF Study. Neuro Oncol 2018. [DOI: 10.1093/neuonc/noy139.017] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
31
|
Vincent F, Rauch A, Loobuyck V, Nix C, Vincentelli A, Leprince P, Smadja D, Jansen P, Debry N, Moussa M, Carpentier A, Spillemaeker H, Lenting P, Susen S, Van Belle E. P2659Modulation of the acquired VWF defect by arterial pulsatility in continuous-flow mechanical circulatory devices. Eur Heart J 2018. [DOI: 10.1093/eurheartj/ehy565.p2659] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
32
|
Montero AS, Bielle F, Goldwirth L, Lalot A, Beccaria K, Pradat PF, Salachas F, Carpentier A. Ouverture transitoire de la barrière hémato-médullaire de lapin par ultrasons pulsés de faible intensité. Neurochirurgie 2018. [DOI: 10.1016/j.neuchi.2018.05.015] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
33
|
Jouffroy R, Saade A, Ellouze S, Carpentier A, Michaloux M, Carli P, Vivien B. Prehospital triage of septic patients at the SAMU regulation: Comparison of qSOFA, MRST, MEWS and PRESEP scores. Am J Emerg Med 2018; 36:820-824. [DOI: 10.1016/j.ajem.2017.10.030] [Citation(s) in RCA: 24] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/20/2017] [Revised: 10/10/2017] [Accepted: 10/10/2017] [Indexed: 01/04/2023] Open
|
34
|
Fischer EC, Chachques J, Garcia A, Pichel R, Morales M, Carpentier A. Temporary Mechanical Circulatory Support for Severe Cardiac Failure: Experimental Study. Int J Artif Organs 2018. [DOI: 10.1177/039139889101400804] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
35
|
Jouffroy R, Saade A, Carpentier A, Ellouze S, Philippe P, Idialisoa R, Carli P, Vivien B. Triage of Septic Patients Using qSOFA Criteria at the SAMU Regulation: A Retrospective Analysis. PREHOSP EMERG CARE 2017; 22:84-90. [DOI: 10.1080/10903127.2017.1347733] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/13/2023]
|
36
|
Latrémouille C, Roussel J, Kindo M, Leprince P, Duveau D, Tchakgarian B, Perlès J, Jansen P, Carpentier A. Evaluation of a Virtual Implant Technique to Optimise Implantation of a Bioprosthetic Total Artificial Heart. J Heart Lung Transplant 2017. [DOI: 10.1016/j.healun.2017.01.134] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
|
37
|
Mesti T, Bouchemal N, Banissi C, Triba M, Marbeuf-Gueye C, Le Moyec L, Ocvirk J, Savarin P, Carpentier A. P08.41 The metabolic effect of bevacizumab in mutant IDH1 glioma cells assessed by NMR spectroscopy. Neuro Oncol 2017. [DOI: 10.1093/neuonc/nox036.230] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
38
|
Mathon B, Navarro V, Carpentier A, Bielle F, Cornu P, Clemenceau S. Résultats et facteurs pronostiques de la chirurgie de l’épilepsie mésiotemporale associée à une sclérose hippocampique. Neurochirurgie 2017. [DOI: 10.1016/j.neuchi.2016.11.044] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
39
|
Quillien V, Carpentier A, Gey A, Avril T, Tartour E, Sejalon F, Campillo-Gimenez B, Vauleon E. P06.13 A low baseline blood neutrophil count and a high percentage of Treg among leucocytes are associated with an increased overall survival of recurrent high-grade glioma patients treated with Bevacizumab. Neuro Oncol 2016. [DOI: 10.1093/neuonc/now188.104] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
40
|
Laurent C, Penzer F, Letroye B, Carpentier A, Baudry S, Duchateau J. Effect of a strength training method characterized by an incremental number of repetitions across sets and a very short rest interval. Sci Sports 2016. [DOI: 10.1016/j.scispo.2016.04.004] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
41
|
Mammar H, Polivka M, Belkacemi Y, Lot G, Froelich S, Carpentier A, Clemenceau S, Gaillard S, Paquis P, Birtwisle-Peyrottes I, Burel-Vandenbos F, Mokhtari K, Kerrou K, Talbot J, Dendale R, Bondiau P, Pouyssegur J, Mazure N. Hypoxia and Metabolism Regulation in Chordomas: Correlation Between Biology and Clinical Features for Potential Targeted Therapy. Int J Radiat Oncol Biol Phys 2015. [DOI: 10.1016/j.ijrobp.2015.07.774] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
42
|
Poortmans J, Jeannaud F, Baudry S, Carpentier A. Changes in Kidney Functions during Middle-distance Triathlon in Male Athletes. Int J Sports Med 2015; 36:979-83. [DOI: 10.1055/s-0034-1398681] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
43
|
Stragier S, Baudry S, Poortmans JR, Duchateau J, Carpentier A. Contribution of muscle hypertrophy to strength gain after training in elderly adults. Comput Methods Biomech Biomed Engin 2015; 18 Suppl 1:2062-3. [DOI: 10.1080/10255842.2015.1070593] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
44
|
Carpentier A. Valvular xenograft and valvular xenobioprosthesis: Past, present, and future. Adv Cardiol 2015; 27:281-93. [PMID: 7446289 DOI: 10.1159/000383994] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/25/2023]
Abstract
At the present time, glutaraldehyde-preserved porcine valves appear to be a reasonable alternative in valvular replacement. The expected durability limit of 8-15 years with the models currently commercially available is counterbalanced by a lower risk of acute complications; particularly thromboembolism. This allows the patient to be free from drugs and related problems. Our opinion is that the patient should take part in choosing between a bioprosthesis and a mechanical prosthesis. This critical choice will depend upon the relative importance for each individual of an improved quality of life with a bioprosthesis versus a lower risk of reoperation with a mechanical valve.
Collapse
|
45
|
Le Rhun É, Dhermain F, Noël G, Reyns N, Carpentier A, Mandonnet E, Taillibert S, Metellus P. [ANOCEF guidelines for the management of brain metastases]. Cancer Radiother 2015; 19:66-71. [PMID: 25666314 DOI: 10.1016/j.canrad.2014.11.006] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/24/2014] [Accepted: 11/26/2014] [Indexed: 12/30/2022]
Abstract
The incidence of brain metastases is increasing because of the use of new therapeutic agents, which allow an improvement of overall survival, but with only a poor penetration into the central nervous system brain barriers. The management of brain metastases has changed due to a better knowledge of immunohistochemical data and molecular biological data, the development of new surgical, radiotherapeutic approaches and improvement of systemic treatments. Most of the time, the prognosis is still limited to several months, nevertheless, prolonged survival may be now observed in some sub-groups of patients. The main prognostic factors include the type and subtype of the primitive, age, general status of the patient, number and location of brain metastases, extracerebral disease. The multidisciplinary discussion should take into account all of these parameters. We should notice also that treatments including surgery or radiotherapy may be proposed in a symptomatic goal in advanced phases of the disease underlying the multidisciplinary approach until late in the evolution of the disease. This article reports on the ANOCEF (French neuro-oncology association) guidelines. The management of brain metastases of breast cancers and lung cancers are discussed in the same chapter, while the management of melanoma brain metastases is reported in a separate chapter due to different responses to the brain radiotherapy.
Collapse
|
46
|
Mathon B, Bédos-Ulvin L, Baulac M, Dupont S, Navarro V, Carpentier A, Cornu P, Clemenceau S. Évolution des idées et des techniques, et perspectives d’avenir en chirurgie de l’épilepsie. Rev Neurol (Paris) 2015; 171:141-56. [DOI: 10.1016/j.neurol.2014.09.010] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/12/2014] [Revised: 08/10/2014] [Accepted: 09/30/2014] [Indexed: 10/24/2022]
|
47
|
Métellus P, Tallet A, Dhermain F, Reyns N, Carpentier A, Spano JP, Azria D, Noël G, Barlési F, Taillibert S, Le Rhun É. Stratégie globale de prise en charge des métastases cérébrales : une approche multidisciplinaire. Cancer Radiother 2015; 19:61-5. [DOI: 10.1016/j.canrad.2014.11.009] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/26/2014] [Accepted: 11/26/2014] [Indexed: 11/30/2022]
|
48
|
Zanello M, Peyre M, Mokhtari K, Boch A, Capelle L, Carpentier A, Clemenceau S, Karachi C, Navarro S, Nouet A, Reina V, Sanson M, Cornu P, Kalamarides M. Méningiomes multi-récidivants : établissement de critères de réponse thérapeutiques après analyse des cinétiques de croissance et des types de récidive. Neurochirurgie 2014. [DOI: 10.1016/j.neuchi.2014.10.031] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
49
|
Latremouille C, Duveau D, Cholley B, Zilberstein L, Bruneval P, Perles J, Jansen P, Carpentier A. 131 * CHRONIC ANIMAL EXPERIENCE WITH THE CARMAT BIOPROSTHETIC ARTIFICIAL HEART. Interact Cardiovasc Thorac Surg 2014. [DOI: 10.1093/icvts/ivu276.131] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
50
|
Chauvet D, Carpentier A, Cornu P, Hans S. Transoral Robot-Assisted Approach of the Sella: Preliminary Feasibility on Cadavers. J Neurol Surg B Skull Base 2014. [DOI: 10.1055/s-0034-1383951] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|